👤 Adnan Derti

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction

1

Articles

articles

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced

Carla M L van Herpen, Sanjiv S Agarwala, Axel Hauschild +14 more · 2019 · Oncotarget · Impact Journals · added 2026-04-24

Carla M L van Herpen, Sanjiv S Agarwala, Axel Hauschild, Carola Berking, J Thaddeus Beck, Dirk Schadendorf, Rob Jansen, Paola Queirolo, Paolo A Ascierto, Christian U Blank, Michael C Heinrich, Rupam R Pal, Adnan Derti, Victor Antona, Heidi Nauwelaerts, Angela Zubel, Reinhard Dummer Show less

📄 PDF DOI: 10.18632/oncotarget.26753

1